By Chris Hutching
|
Friday 27th October 2000 |
Text too small? |
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
TRU - Resignation of CEO, Martin Dillon
HGH - Heartland confirms endorsement of TSB Heartland Bank CEO
Devon Funds Morning Note - 02 October 2026
TEM - Transaction in Own Shares
SPK - Notice of Annual Meeting and Proxy Form
October 2nd Morning Report
AFI - Dividend Guidance for FY27 and Move to Quarterly Dividends
SKO - Serko FY27 Interim Results Announcement Date - 16 November
NZK - Proposed Share Transaction Requiring Shareholder Approval
BIF - capital commitment made to BIF